Significant clinical improvement of psoriasis was observed in an inactive chronic HBV patient with positive HBsAg, HBsAb of <5 mlU/mL, positive total HBcAb, and a low HB viral DNA level of 10 IU/mL with tenofovir, an antiviral drug used to treat HBV, reported by Chung et al. in 2023 [70]. Here, GSTM1 is linked to psoriasis.